DHR - Repligen: Replicating Great Returns

• Repligen has seen another few very strong years, as its capital allocation track record remains impressive.
• The company has furthermore benefited from the pandemic, as organic growth has been very strong as well.
• I like the long-term potential, and while shares have seen a recent pullback, valuations remain demanding but probably worthwhile in the long haul.

For further details see: